Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RecQ protein-like pseudogene (ENSG00000274584) is a pseudogene, meaning it represents a non-functional copy or fragment of a gene that once encoded a member of the RecQ DNA helicase family, but it does not produce a functional helicase protein. Pseudogenes typically arise via gene duplication or retrotransposition followed by the accumulation of disabling mutations, rendering them inactive. They do not encode functional proteins, may not be expressed, and are not considered drug targets or directly involved in disease mechanisms or therapy response algorithms[4][5]. Where functional, RecQ proteins play roles in genomic stability and DNA repair, but this specific pseudogene does not.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RecQ protein-like pseudogene.